Tamara Lyn Dunlap Dds Pllc in Johnstown, NY - Dentist

Tamara Lyn Dunlap Dds Pllc is a dental clinic (Dentist - General Practice) in Johnstown, New York. The current practice location for Tamara Lyn Dunlap Dds Pllc is 310 Jansen Ave, Johnstown, New York. For appointments, you can reach them via phone at (518) 762-4321. The mailing address for Tamara Lyn Dunlap Dds Pllc is 310 Jansen Ave, Johnstown, New York and phone number is (518) 762-4321.

Tamara Lyn Dunlap Dds Pllc is licensed to practice in New York (license number 048515) and its NPI number is 1942676606. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (518) 762-4321.

Contact Information

	Tamara Lyn Dunlap Dds Pllc
	310 Jansen Ave Johnstown NY 12095-1909
	(518) 762-4321
	(518) 762-4323

Dental Care Clinic Profile

Full Name	Tamara Lyn Dunlap Dds Pllc
Speciality	Dentist - General Practice
Location	310 Jansen Ave, Johnstown, New York
Authorized Official Name and Position	Tamara Dunlap (OWNER/PROVIDER)
Authorized Official Contact	5187624321
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Tamara Lyn Dunlap Dds Pllc 310 Jansen Ave Johnstown NY 12095-1909 Ph: (518) 762-4321	Tamara Lyn Dunlap Dds Pllc 310 Jansen Ave Johnstown NY 12095-1909 Ph: (518) 762-4321

NPI Details:

NPI Number	1942676606
Provider Enumeration Date	08/18/2015
Last Update Date	08/18/2015

Medical Identifiers

Medical identifiers for Tamara Lyn Dunlap Dds Pllc such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1942676606	NPI	-	NPPES
03016277	Medicaid	NY
9210579	Other	NY	DENTAQUEST

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1223G0001X	Dentist - General Practice	048515 (New York)	Primary

News Archive

Around-the-clock visitation during patient's stay improves patient satisfaction

Regardless of the circumstances, hospitalization can be a fearful thing. Patients find themselves in a new environment, surrounded by new people, new sights, new sounds - and often, the only thing that can quell that strange sense of unfamiliarity is having a loved one there to visit.

VEGF is key target for new anti-angiogenesis drugs, Spanish team reports

Analyzing the expression of particular genes in lung cancers could soon allow researchers to identify groups of patients who are likely to benefit most from treatment with angiogenesis-inhibitor drugs, a Spanish team reports.

India's CNBC-TV18 examines implications of country's decision to issue compulsory license for Bayer cancer drug

"India's grant of a compulsory license to Natco for Bayer's kidney-cancer drug Nexavar has sent shockwaves across the globe," but "India has found a backer in the World Health Organization," CNBC-TV18's "moneycontrol.com" reports.

Bolton Medical reports first U.S. trial of its Relay Plus System for endovascular stent-graft procedures

Bolton Medical announced today the first use of its new Relay Plus System in the U.S. Relay Clinical Trial. The case took place at the University of Pennsylvania Medical Center in Philadelphia, PA.

Tamara Lyn Dunlap Dds Pllc - Dental Clinic in Johnstown, NY